FTSE 100 clocks all-time closing high

The FTSE 100 (INDEXFTSE:UKX) closes in on its record intra-day high, too.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Updated — 16.30 29/12/16 — While many Brits slump on sofas following the excesses of Christmas, the FTSE 100 is no slouch — after closing yesterday at a record high of 7,106.08, beating the previous end-of-day peak of 7,103.98 gained in April 2015, at the close of trade today it finished even higher, on 7,120.26.

Saint Nicholas has shown that he hasn’t clocked off yet after finishing his Xmas Eve rounds, with the Santa Rally continuing its momentum from the beginning of the month. 

As the US dollar further strengthens against the pound, London’s largest listed companies are benefiting from the c.70% of revenue they earn from abroad.

Generally, the Footsie’s main beneficiaries of weak sterling are exporters in fields such as oil, mining and pharmaceuticals, so the likes of BP, Shell, Rio Tinto, BHP Billiton, GlaxoSmithKline and AstraZeneca have all risen since early December.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Sam Robson owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca, BP, and Rio Tinto. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »